Evidence that public database records for many cancer-associated genes reflect a splice form found in tumors and lack

Meenakshi Roy1, Qiang Xu, Christopher Lee

  • 1Molecular Biology Institute, Center for Genomics and Proteomics, Department of Chemistry and Biochemistry, University of California Los Angeles, Los Angeles, CA 90095-1570, USA.

Nucleic Acids Research
|September 9, 2005
PubMed

Insights

Many cancer-associated genes have previously unknown splice forms in normal tissues. Re-evaluating these normal splice forms is crucial for understanding gene function in both health and cancer.

Area of Science:

  • Genomics
  • Molecular Biology
  • Bioinformatics

Background:

  • Alternative splicing generates diverse transcript isoforms from a single gene.
  • Cancer tissues often exhibit distinct splice forms compared to normal tissues.
  • Existing cDNA databases may not fully represent normal tissue transcriptomes due to historical cloning biases from tumor samples.

Purpose of the Study:

  • To identify novel splice forms, particularly in-frame exon skipping events, in normal human tissues for a panel of 50 cancer-associated genes.
  • To assess the representation of normal versus tumor-associated splice forms in public databases.
  • To provide a comprehensive database of novel normal splice forms.

Main Methods:

  • Bioinformatic analysis of gene sequences.
  • Reverse transcription polymerase chain reaction (RT-PCR) on normal tissue samples.
  • Comparison of identified splice forms with existing databases like GenBank.

Main Results:

  • Previously unknown splice forms were identified in normal tissues for nearly two-thirds of the studied cancer-associated genes.
  • Approximately 40% of these novel normal splice forms were found to be the dominant splice form.
  • Tumor-associated splice forms were twice as prevalent in GenBank compared to normal tissue forms, reflecting cloning biases.
  • A novel normal splice form of IKBbeta, a key regulator of the NF-kappaB pathway, was identified.
  • A database of 1308 novel normal splice forms was compiled.

Conclusions:

  • Normal tissues harbor a significant number of previously undiscovered splice forms for cancer-associated genes.
  • The current understanding of transcript isoforms in public databases is skewed towards tumor-associated forms.
  • Systematic investigation of normal tissue splice forms is essential for a complete understanding of gene function in normal physiology and cancer pathogenesis.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...